InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Smith Patrick F, Président, Développement Intégré des Médicaments. Insider active across 2 companies, notably Certara, Inc.. Aggregated, 13 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €989k. History available since 1 November 2021. The latest transaction was filed on 7 October 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Smith Patrick F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
5,409 股@ US$11.035.0% 占其流量Common StockSEC:0001415889-24-024874:0
7,151 股0Common StockSEC:0001415889-24-024816:0
5,264 股@ US$16.767.5% 占其流量Common StockSEC:0001415889-24-010291:0
1,532 股@ US$17.882.3% 占其流量Common StockSEC:0001415889-24-010073:0
5,000 股@ US$18.007.6% 占其流量Common StockSEC:0001415889-24-004633:0
19,104 股@ US$21.5535.2% 占其流量Common StockSEC:0001415889-23-009326:0
1,532 股@ US$23.803.1% 占其流量Common StockSEC:0001415889-23-005808:0
2,387 股@ US$13.482.9% 占其流量Common StockSEC:0001415889-22-011348:0
1,244 股@ US$12.231.4% 占其流量Common StockSEC:0001415889-22-011013:0
10,000 股@ US$17.7115.9% 占其流量Common StockSEC:0001415889-22-008824:0
10,000 股@ US$19.1616.4% 占其流量Common StockSEC:0001415889-22-006381:0
1,532 股@ US$21.482.7% 占其流量Common StockSEC:0001415889-22-003827:0
3,631 股0Common StockSEC:0001415889-21-005033:0
13 条申报中的 13 条
About Smith Patrick F
SMITH PATRICK F is a Président, Développement Intégré des Médicaments, associated with Certara, Inc. (XNAS). The declarant has 13 filings in total. In the sampled recent filings from 2021-11-01 to 2024-10-08, there were only sales, for a total of EUR 988961.
